Combined ROS Sensitive PEG-PPS-PEG with Peptide Agonist for Effective Target Therapy in Mouse Model
ROS-responsive PEG-PPS-PEG polymers provide a novel and effective platform for the targeted delivery of GHRH agonist peptides, improving cardiac function and offering a new approach for peptide therapy in MI treatment.
Authors
- Hong Yu (ORCID: https://orcid.org/0000-0003-0521-8933)
- Pingping Xiang (ORCID: https://orcid.org/0000-0001-8685-9673)
- Wangwei Jing
- Qi Liu (ORCID: https://orcid.org/0000-0002-2103-0781)
- Yaping Wang (ORCID: https://orcid.org/0000-0001-9548-5124)
Institutions
- Ministry of Education (NZ)
- Sir Run Run Shaw Hospital (CN)
- Molecular Devices (United Kingdom) (GB)
- Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine (CN)
- Second Affiliated Hospital of Zhejiang University (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- International Journal of Nanomedicine
- Published
- 2024-09-01
- DOI
- https://doi.org/10.2147/ijn.s471036
- Citations
- 6
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 1.04
Funders
- National Natural Science Foundation of China
- Zhejiang University
- Science and Technology Program of Zhejiang Province